Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

4.3%

1 terminated out of 23 trials

Success Rate

92.3%

+5.8% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

42%

5 of 12 completed with results

Key Signals

5 with results92% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (8)
Early P 1 (3)
P 2 (5)

Trial Status

Completed12
Recruiting2
Unknown2
Active Not Recruiting2
Withdrawn2
Suspended1

Trial Success Rate

92.3%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT03076281Phase 2TerminatedPrimary

Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma

NCT03109171Not ApplicableRecruiting

Accuracy of the Sensory Test Using the Laryngopharyngeal Endoscopic Esthesiometer in Obstructive Sleep Apnea

NCT03269396Not ApplicableSuspended

Laryngeal Allograft Transplantation

NCT03529422Phase 2Active Not RecruitingPrimary

Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN

NCT03854032Phase 2Active Not Recruiting

Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck

NCT05565430Completed

Vocal Cord Responses During Hyperventilation in Normal Individuals and in Mild and Severe Asthmatics.

NCT03109873Early Phase 1CompletedPrimary

Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer

NCT03238365Early Phase 1Completed

Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck

NCT03162731Early Phase 1CompletedPrimary

Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer

NCT05636410CompletedPrimary

Ultrasound Assessment of the Larynx and Trachea in the Neonatal Period

NCT06480084Not ApplicableNot Yet Recruiting

Prevalence of EILO Among Children With Asthma

NCT06439290Not ApplicableRecruiting

Voice Outcome of Glottoplasty, Cricothyroid Approximation, Thyroplasty, and Chondrolaryngoplasty

NCT03737968Phase 2Unknown

Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients.

NCT02126969Phase 2Completed

A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN

NCT05746780Completed

Bilateral Elective Neck Dissection in Salvage Total Laryngectomy

NCT05145556Not ApplicableUnknown

Teach Intubation by Novices in Anaesthesiology

NCT04168671Not ApplicableWithdrawnPrimary

CLE During Exercise Testing in Asthma

NCT02065128Withdrawn

The Efficacy of Capsaicin Sensitivity Testing in Patients With Irritable Larynx Syndrome

NCT03030781CompletedPrimary

Relationship of Cricoid With the Right and Left Bronchial Diameters in the Pediatric Population Using Three-dimensional Imaging.

NCT02761239Not ApplicableCompletedPrimary

Innervation of Human Cricopharyngeal Muscle By Recurrent Laryngeal and External Branch of Superior Laryngeal Nerve

Scroll to load more

Research Network

Activity Timeline